Portage Biotech重新命名为Alphaton Capital,在与电报相关的Toncoin(TON)中投资了1亿美元。此举突出了Telegram的1B+用户和最近集成的潜在潜在的。首席执行官布列塔尼·凯瑟(Brittany Kaiser)强调了吨的增长曲线,而公司计划通过Staking,Defi和生态系统企业部署令牌。股票较早上升,但关闭略低。了解Alphaton如何将自己与其他加密纪念品区分开,以及对Ton的未来的广泛影响。 Key takeaways: - AlphaTON Capital shifts focus to TON treasury with $100M in TON tokens - TON's integration with Telegram's 1B+ users drives mass adoption potential - Strategy includes network validation, staking, and DeFi activities - CEO cites TON's 'explosive growth curve' post-Telegram integration - Shares of PRTG rose before closing slightly lower - TON token price remains flat at $3.19 but down 36% year-to-date - Company保持传统生物技术操作,同时旋转加密 - 动词技术和其他公司的类似举动表示对TON的兴趣日益增加